Gallant
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10865 Rd to the Cure Ste 101, San Diego,...Phone Number
(855) 442-5526Website
www.gallant.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Gallant
Gallant is an animal health biotechnology company creating a new category of veterinary medicine with a pipeline of off-the-shelf stem cell therapies targeting the root causes of diseases in pets. Led by pioneers in veterinary regenerative medicine with deep expertise in development, manufacturing, and commercialization, Gallant is making regenerative medicine accessible moving beyond symptom management to restoring health at the source.Explore more
Gallant Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gallant your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Gallant
Check if Gallant has recently received funding, and reach out quickly before it becomes old news!
Click to see if Gallant had a recent Job posting/layoffs
Check out if Gallant is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Gallant launches new products
Earning: See what the market has to say on Gallant recently announced quarterly report
Gallant, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Gallant has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Gallant
Find 3 more new buyers
Compare Similar Companies to Gallant
Compare insights from companies similar to Gallant, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gallant is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Gallant is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Gallant.
Gallant financials insights
Gather financial insights about Gallant, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$18M
Private Equity
$10.2M
Gallant Tech Stack
A closer look at the technologies used by Gallant
Most Recent Scoops
Open Position
Person-Based
Funding
, according to a recent Form D filing, has secured $10,174,361 in Private Equity funding.
Funding
Funding
Funding
Executive Move
Board of Directors
Gallant News & Media
Gallant Reports Positive Pilot Data for Feline Osteoarthritis Stem Cell Therapy; Receives FDA Eligibility for Expanded Conditional Approval Pathway
Randomized, placebo-controlled study shows over 76% of treated cats demonstrated improved quality of life SAN DIEGO, April 15, 2026 /PRNewswire/ -- Gallant, an animal health biotechnology company pioneering off-the-shelf stem cell therapies for pets, today announced positive results from...National Survey: Veterinary Professionals See Stem Cell Therapy as a Powerful New Tool for Inflammatory Diseases in Pets
Gallant and AAHA survey finds 95% believe stem cell therapy will become a standard treatment option in the spectrum of care within the next decade SAN DIEGO, March 2, 2026 /PRNewswire/ -- Results from a new veterinary survey titled "Regenerative Medicine in Veterinary Practice:...Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics
Agreement establishes first ultra-low temperature cold chain in veterinary medicine ahead of anticipated potential first FDA-approved, off-the-shelf stem cell therapy SAN DIEGO, Feb. 27, 2026 /PRNewswire/ -- Gallant, an animal health biotechnology company pioneering off-the-shelf stem...FDA Completes Safety for Gallant's First Ready-to-Use Stem Cell Therapy for Refractory FCGS
Gallant achieves FDA "Technical Section Complete" for Target Animal Safety (TAS), a key requirement in the approval process for a drug. The product is sonruvetcel injectable suspension—a potential first-in-class, uterine-derived allogeneic mesenchymal stromal cell therapy for cats with...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gallant
Sign Up For FreeTo access detailed company insights
Gallant is an animal health biotechnology company creating a new category of veterinary medicine with a pipeline of off-the-shelf stem cell therapies targeting the root causes of diseases in pets. Led by pioneers in veterinary regenerative medicine with deep expertise in development, manufacturing, and commercialization, Gallant is making regenerat... Read More
